Neurogene Inc. Ratios

Ratios Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 81,012.71%20,348.07%5,327.49%3,702,700.00%1,253,125.00%-124.26%-7.10%788,385.71%188,071.43%-8,184.43%
EBIT Margin 80,912.71%20,248.07%5,227.49%3,764,500.00%1,277,975.00%-130.50%-7.10%807,385.71%198,510.71%-8,930.27%
EBITDA Margin 81,459.32%20,336.42%5,328.38%3,688,100.00%1,252,100.00%-126.06%-6.94%807,385.71%198,510.71%-8,930.27%
Operating Margin 3,764,500.00%1,277,975.00%-130.50%-7.10%807,385.71%198,510.71%-8,930.27%
Net Margin 81,459.32%20,336.42%5,327.45%3,702,700.00%1,253,125.00%-124.26%-7.10%788,385.71%188,071.43%-8,184.43%
FCF Margin 76,437.69%18,251.29%3,902.44%3,093,900.00%1,130,300.00%-126.50%-1.63%786,485.71%184,796.43%-7,720.11%
Efficiency
Assets Average 112.32M279.15M
Equity Average 107.18M248.20M
Invested Capital 72.67M141.90M186.13M310.45M
Asset Utilization Ratio 8.900.00
Leverage & Solvency
Interest Coverage Ratio -809.13-202.48-52.27-0.04M-0.01M-0.01M-0.07M-0.01M-0.00M-52.68
Equity Ratio 0.940.960.840.92
Times Interest Earned -809.13-202.48-52.27-0.04M-0.01M-0.01M-0.07M-0.01M-0.00M-52.68
Valuation
Enterprise Value 80.21M214.81M386.72M275.95M-26.09M329.17M21.68M-151.62M27.17M
Market Capitalization 386.72M275.95M50.84M472.26M21.68M45.53M339.58M
Return Ratios
Return on Sales 814.59%203.36%53.27%-1.24%-0.07%-81.84%
Return on Capital Employed -0.66%-0.31%
Return on Assets -0.63%-0.27%
Return on Equity -0.66%-0.31%